Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

PPROPANC BIOPHARMA, INC.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
P

PROPANC BIOPHARMA, INC.

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Similar companies
  • News
  • Insider Transactions
Loading insider transactions

Insider transactions

Insider sentiment

Insider transactions

Insider sentiment

No buy/sell activity
DateNameTitleSharesValueTransactionSource
Jul 5, 2023ZELINGER JOSEFDirector15,000,000Common Stock Purchase Warrant$3TGrant / award
Aug 17, 2021Nathanielsz James AndrewCEO/CFO8,728,000Common stock, par value $0.001$391.5TGrant / award
Aug 17, 2021Kenyon Julian NormanChief Scientific Officer3,420,000Common stock, par value $0.001$153.4TGrant / award
May 14, 2019Kenyon Julian NormanChief Scientific Officer9,750,000Restricted Stock Units$65,812,500TGrant / award
May 14, 2019Kenyon Julian NormanChief Scientific Officer9,750,000Stock Options (Right to Buy)$65,812,500TGrant / award
May 14, 2019Nathanielsz James AndrewCEO, Acting CFO, Chairman19,500,000Restricted Stock Units$131,625,000TGrant / award
May 14, 2019Nathanielsz James AndrewCEO, Acting CFO, Chairman19,500,000Stock Options (Right to Buy)$131,625,000TGrant / award
Apr 14, 2016Kenyon Julian NormanDirector71,500,000Stock Option (Right to Buy)$6,594,711,006,351.2TGrant / award
Apr 14, 2016Nathanielsz James AndrewCEO, CFO, Secretary, Treasurer71,500,000Stock Option (Right to Buy)$6,594,711,006,351.2TGrant / award
Feb 4, 2015Kenyon Julian NormanDirector17,654,470Common Stock, par value $0.001$1,628,337,449,234.9TOther
  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • Insider Transactions
$0.65Close ยท Sep 22, 2026